Surviving Lymphoma: Stress & PTSD

Cancer is a stressful disease to deal with. There are harsh treatments, painful symptoms, and the threat of death, along with financial worries, employment concerns, and relationships to manage. Self-esteem usually suffers, too, especially if a patient experiences alopecia (hair loss). Stress can lead to anxiety, restlessness, and physical illness such as nausea.

Since there are so many possible sources of stress, it's impossible to fully cure or reduce it. However, relaxation techniques, spiritual beliefs, and positive thinking can help. If you experience stress, try to identify what's bothering you and talk about your problems to your loved ones.

Stress can continue into remission, so figure out which coping techniques work for you and keep at them. Meditation, acupuncture, and therapy are all valid methods. Try anything that you think may help you.

Post-Traumatic Stress Disorder (PTSD)

Lymphomas can cause lasting stress once a patient enters remission. PTSD is becoming a recognized late effect of cancer treatments as the number of survivors increases every year. Talk to your doctor if you can't manage your stress.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap